The Clorox Company logo CLX - The Clorox Company

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 3
HOLD 20
SELL 6
STRONG
SELL
0
| PRICE TARGET: $100.50 DETAILS
HIGH: $127.00
LOW: $83.00
MEDIAN: $97.50
CONSENSUS: $100.50
UPSIDE: 2.76%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 80% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Fair Value Mild
Trading 13.3% below fair value
Current Price $97.80
Bear Case $92.91 5.0% downside ($92.91 - $97.80) / $97.80 = -5.0% $6.88 × 14x P/E
Fair Value $112.81 15.4% upside ($112.81 - $97.80) / $97.80 = 15.4% $6.88 × 17x P/E
Bull Case $132.73 35.7% upside ($132.73 - $97.80) / $97.80 = 35.7% $6.88 × 20x P/E

Adjust Assumptions

17.0x
6.88$

Key Value Driver

Normalized P/E multiple (17x base case)

Implied Market Multiple 14.2x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $100.50 from 29 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $112.81 per share.

Warnings

Dividend-based valuation: $75.51 (below our primary estimate by 35%). Large gaps may signal the dividend doesn't reflect full earning power.

Key Risks

  • Growth DCF inappropriate — terminal value assumptions dominate
  • EV/EBITDA misleading for regulated businesses where capex is mandated
  • Regulatory risk is a fat tail not visible in normal multiples